Trial Profile
An Open-Label Single-Sequence Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-Dose Pharmacokinetics of BMS-986177 in Healthy Subjects
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Sep 2016
At a glance
- Drugs BMS 986177 (Primary) ; Diltiazem; Itraconazole
- Indications Thrombosis
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 09 Sep 2016 Status changed from not yet recruiting to completed.
- 25 Jun 2016 New trial record